Janus Henderson Group’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.52M Hold
63,877
﹤0.01% 1180
2025
Q1
$1.99M Hold
63,877
﹤0.01% 1279
2024
Q4
$2.23M Buy
63,877
+4,900
+8% +$171K ﹤0.01% 1254
2024
Q3
$2.36M Hold
58,977
﹤0.01% 1228
2024
Q2
$2.81M Sell
58,977
-740
-1% -$35.3K ﹤0.01% 1096
2024
Q1
$2.59M Buy
59,717
+14
+0% +$607 ﹤0.01% 1168
2023
Q4
$3.02M Sell
59,703
-103
-0.2% -$5.21K ﹤0.01% 1041
2023
Q3
$2.71M Buy
59,806
+4
+0% +$181 ﹤0.01% 1029
2023
Q2
$2.45M Sell
59,802
-57
-0.1% -$2.34K ﹤0.01% 1140
2023
Q1
$2.14M Buy
59,859
+6,137
+11% +$219K ﹤0.01% 1216
2022
Q4
$2.03M Buy
53,722
+7,442
+16% +$281K ﹤0.01% 1092
2022
Q3
$2.05M Buy
46,280
+23,073
+99% +$1.02M ﹤0.01% 1278
2022
Q2
$858K Sell
23,207
-2,516
-10% -$93K ﹤0.01% 1424
2022
Q1
$953K Buy
25,723
+7
+0% +$259 ﹤0.01% 1546
2021
Q4
$783K Buy
25,716
+11,968
+87% +$364K ﹤0.01% 1619
2021
Q3
$461K Buy
+13,748
New +$461K ﹤0.01% 1656
2021
Q2
Sell
-76,644
Closed -$3.45M 1637
2021
Q1
$3.45M Buy
76,644
+26,018
+51% +$1.17M ﹤0.01% 1086
2020
Q4
$2.86M Sell
50,626
-10,053
-17% -$568K ﹤0.01% 1070
2020
Q3
$2.88M Sell
60,679
-8,848
-13% -$420K ﹤0.01% 995
2020
Q2
$4.1M Buy
69,527
+22,253
+47% +$1.31M ﹤0.01% 944
2020
Q1
$2.24M Sell
47,274
-154,438
-77% -$7.3M ﹤0.01% 990
2019
Q4
$12.2M Sell
201,712
-380,819
-65% -$23M 0.01% 929
2019
Q3
$34.9M Buy
582,531
+274,852
+89% +$16.5M 0.02% 689
2019
Q2
$19.8M Buy
307,679
+211,161
+219% +$13.6M 0.01% 796
2019
Q1
$7.83M Buy
96,518
+84,587
+709% +$6.87M ﹤0.01% 939
2018
Q4
$645K Buy
+11,931
New +$645K ﹤0.01% 1206
2018
Q2
Sell
-14,300
Closed -$630K 1412
2018
Q1
$630K Buy
+14,300
New +$630K ﹤0.01% 1266
2016
Q3
Sell
-12,763
Closed -$297K 831
2016
Q2
$297K Hold
12,763
﹤0.01% 797
2016
Q1
$517K Hold
12,763
﹤0.01% 755
2015
Q4
$791K Hold
12,763
0.01% 682
2015
Q3
$516K Hold
12,763
﹤0.01% 737
2015
Q2
$734K Hold
12,763
0.01% 734
2015
Q1
$812K Buy
+12,763
New +$812K 0.01% 727